Triiodothyronine augmentation in the treatment of refractory depression: A meta-analysis

Archives of General Psychiatry

Volumn 53, Issue 9, 1996, Pages 842-848

  Aronson, Ronnie ^a   Offman, Hilary J ^b   Joffe, Russel T ^c   David Naylor, C ^a,b,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DESIPRAMINE; IMIPRAMINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE SODIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EUTHYROIDISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0029786561     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830090090013     Document Type: Article

References (60)

1. Weissman MM, Leal PJ, Tischler GL, Blazer DG, Karno M, Bruce ML, Florio LP. Affective disorders in five United States communities. Psychol Med. 1988;18:141-153.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association: 1987.
3. Tasman A, Goldfinger SM, Kaufman CA. American Psychiatric Press Review of Psychiatry. Washington, DC: American Psychiatric Press; 1990:9.
4. Roose SP, Glassman AH, Walsh BT, Woodring S. Tricyclic nonresponders: phenomenology and treatment. Am J Psychiatry. 1986;143:345-348.
5. Flach FF, Celian CI, Rawson RW. Treatment of psychiatric disorders with triiodothyronine. Am J Psychiatry. 1958;114:841-842.
6. Feldmesser-Reiss EE. The application of triiodothyronine in the treatment of mental disorders. J Nerv Ment Dis. 1958;127:540-545.
7. Prange AJ Jr, Wilson IC, Rabon AM, Lipton AM. Enhancement of imipramine antidepressant effect by thyroid hormone. Am J Psychiatry. 1969;126:457-469.
8. Wilson IC, Prange AJ Jr, McClane TK, Rabon AM, Lipton AM. Thyroid- hormone enhancement of imipramine in non-retarded depressions. N Engl J Med. 1979;282:1063-1067.
9. Wheatley D. Potentialion of amitryptyline by thyroid hormone. Arch Gen Psychiatry. 1972;26:229-233.
10. Coppen A, Whybrow PC, Noguera R, Maggs R, Prange AJ Jr. The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry. 1972;26:234-241.
11. Tsutsui S, Yamazaki Y, Namba T, Tsushima M. Combined therapy of T3 and antidepressants in depression. J Int Med Res. 1979;7:138-146.
12. Ogura C, Okuma T, Uchida Y, Imai S, Yogi H. Combined thyroid (triiodothyronine)- tricyclic antidepressive treatment in depressive states. Folia Psychiatr Neurol Jpn. 1974;28:179-186.
13. Earle BV. Thyroid hormone and tricyclic antidepressants in resistant depressions. Am J Psychiatry. 1970;126:1667-1669.
14. Schwarcz G, Halaris A, Baxter L, Escobar J, Thompson M, Young M. Normal thyroid function in desipramine nonresponders converted to responders by the addition of L-triiodothyronine. Am J Psychiatry. 1984;141:1614-1616.
15. Nakamura T, Nornura J. Comparison of thyroid function between responders and nonresponders to thyroid hormone supplementation in depression. Jpn J Psychiatry Neourol. 1992;46:905-909.
16. Nemerott CB. Augmentation regimens for depression. J Clin Psychiatry. 1991;52(suppl):21-27.
17. Nierenberg AA. What next? a review of pharmacologic strategies for treatment- resistant depression. Psychopharmacol Bull. 1990;26:429-460.
18. Extein IL, Gold MS. Thyroid hormone potentiation of tricyclic antidepressants. In: Extein IL, ed. Treatment of Tricyclic-Resistant Depression. Washington. DC: American Psychiatric Press: 1989:29-48
19. Stern RA, Nevels CT, Shelhorse ME, Prohaska ML, Mason GA, Prange AJ Jr. Antideoressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings. Biol Psychiatry. 1991;30: 623-627.
20. Joffe RT. Triiodothyronine potentiation of the antidepressant effect of phenelzine. J Clin Psychiatry 1988;49:409-410.
21. Joffe RT Triiodothyronine potentiation of fluoxetine in depressed patients. Can J Psychiatry. 1992;37:48-49.
22. Stancer HC, Persad E. Treatment of intractable rapid-cycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry. 1982;39:311-312.
23. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. Arch Gen Psychiatry. 1990;47:435-440.
24. Stein MB, Uhde TW. Triiodothyronine potentiation of tricyclic antidepressant treatment in patients with panic disorder. Biol Psychiatry. 1990;28:1061- 1064.
25. Pigott TA, Pato MT, L'Heureaux F, Hill JL, Grover GN, Bernstein SE. Murphy DL. A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorder. J Clin Psychopharmacol. 1991;11:242-248.
26. Stein D, Avni J. Thyroid hormones in the treatment of affective disorders. Acta Psychiatr Scand. 1988;77:623-636.
27. Verdoux H, Peyre F, Bourgeois M. Potentiation of antidepressive treatment by thyroid hormone therapy. Encephale. 1989;15:517-522.
28. Patten SB, Lupin DA, Boucher SA, Lamarre CJ. Pharmacologic management of refractory depression. Can Med Assoc J 1992;146:483-487.
29. Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC. Meta- analyses of randomized controlled trials. N Engl J Med. 1987;316:450-455.
30. Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbe KA. Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol. 1992;45:255-265.
31. Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2:31-49.
32. Goodwin FK, Prange AJ, Post RM, Muscettola G, Lipton MA. Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry. 1982;139:34-38
33. Gitlin MJ, Weiner H, Fairbanks L, Hershman JM, Friedfeld N. Failure of T3 to potentiate tricyclic antidepressant response. J Affective Disord. 1987;13:267- 272.
34. Banki C. The use of triiodothyronine in the treatment of depression [in Hungarian]. Orv Hetil. 1975;116:2543-2546.
35. Breslow NE, Clayton EG. Approximate inference in generalized linear mixed models. J Am Stat Assoc 1993;88:9-25.
36. Cox DR, Snell EJ. Analysis of Binary Data. 2nd ed. London, England: Chapman & Hall Ltd: 1989:60-61.
37. DerSimonian R, Laird N. Meta-analysis in controlled clinical trials. Control Clin Trials. 1986;7:177-181.
38. Glass GV. Integrating findings: the meta-analysis of research. In Shulman LS, ed. Review of Research in Education. New York, NY: Peacock Press; 1977:351-379.
39. Hedges LV, Olkin I. Statistical Methods for Meta-analysis. Orlanoo, Fla: Academic Press Inc; 1985:77.
40. Banki CM. Cerebrospinal fluid amine metabolites after combined amitryptyline- triiodothyronine treatment of depressed women. Eur J Clin Pharmacol. 1977;11:311-315.
41. Steiner M, Radwan M, Elizur A, Blum I, Atsmon A, Davidson S. Failure of L- triiodothyronine to potentiate tr cyclic antidepressant response. Curr Ther Res. 1978;23:655-659.
42. Thase ME, Kupfer DJ, Jarrett DB. Treatment of imipramine-resistant recurrent depression. I: an open clinical trial of adjunctive L-triiodothyronine. J Clin Psychiatry. 1989;50:385-388.
43. Joffe RT, Singer W. A comparison of triiodothyronine and thyroxine in the potentiation of tricyclic antidepressants. Psychiatry Res. 1990;32:241-251.
44. Joffe RT, Singer W, Levitt AJ, MacDonald C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry. 1993;50:387-393.
45. Targum SD, Greenberg RD, Harmon RL, Kessler K, Salerian AJ, Fram DH. Thyroid hormone and the TSH stimulaton test in refractory depression. J Clin Psychiatry 1984;45:345-346.
46. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
47. Bunney WE Jr, Hamburg DA. Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 1963;9:280-294.
48. Loosen PT. Hormones of the hypothalamic-pituitary-thyroid axis: a psychoneuroendocrine perspective. Pharmacopsychiatry. 1986;19:401-415.
49. Howland RH. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry. 1993;54:47-54.
50. Joffe RT A perspective on the thyroid and depression. Can J Psychiatry. 1990;35:754-758.
51. Baruch P, Jouvent R, Widlocher D. Increased TSH response to TRH in refractory depressed women. Am J Psychiatry. 1985;142:145-146.
52. Kirkegaard C, Faber J. Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous cepression. Acta Endocrinol. 1981;96:199- 207.
53. Whybrow PC, Coppen A, Prange AJ Jr, Noguera R, Bailey JE. Thyroid function and the response to liothyronine in depression. Arch Gen Psychiatry. 1972;26:242-245.
54. Hatotani N, Nomura J, Yamaguchi T, Kitayama I Clinical and experimental studies of the pathogenesis of depression. Psychoneuroendocrinology. 1977;2:115-130
55. Crantz FR, Suva JE, Larsen PR. An analysis of the sources and quantity of 3,5,3′ -triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology. 1982;110:367-374.
56. Kaplan MM, Yaskoski KA. Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates. J Clin Invest. 1980;66:551-562.
57. Lim VS, Passo C, Murata Y, Ferrari E, Nakamura H, Retetoff S. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only. Endocrinology. 1984;114:280-286.
58. Calvo R, Obregon MJ, Ruiz de Ona C, Ferreiro B, Escobar Del Rey E, Morreale de Escobar G. Thyroid hormone economy in pregnant rats near term: a 'physiological' animal model of nonthyroidal illness? Endocrinology. 1990;127:10- 16.
59. Martin P, Brochet D, Soubrie P, Simon P. Triiodothyronire-induced reversal of learned helplessness in rats. Biol Psychiatry. 1985;201023-1025.
60. Nerenberg AA. Treatment choice after one antidepressant fails: a survey of northeastern psychiatrists. J Clin Psychiatry. 1991;52:383-385.